FDA Inspection 1238496 — Hebei Shengxue Dacheng Pharmaceutical Co., Ltd.
The FDA completed an inspection of Hebei Shengxue Dacheng Pharmaceutical Co., Ltd. on Apr 5, 2024 in Shijiazhuang. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Apr 5, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Shijiazhuang (China)